TF
AMPH icon

Trek Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Trek Financial’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,638
Closed -$284K – 388
2024
Q4 		$284K Buy
7,638
+1,021
+15% +$46.7K 0.02% 339
2024
Q3 		$321K Buy
+6,617
New +$290K 0.02% 296

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trek Financial's AMPH Position: Q1 2025 in Review

Trek Financial sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 7,638 shares — an estimated $284K sold.

Trek Financial first reported a position in AMPH in Q3 2024 and held it in 2 quarters. The position peaked at $321K in Q3 2024. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • Trek Financial reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Trek Financial sold 7,638 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $284K.
  • Trek Financial first reported a position in Amphastar Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Trek Financial's Amphastar Pharmaceuticals position peaked at $321K in Q3 2024.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Trek Financial's 13F filing for Q1 2025, filed 30 Apr 2025.